Vitamin D and IL28B genotyping as predictors for antiviral therapy: A retrospective study in Egyptian HCV genotype 4a
Tropical Journal of Pharmaceutical Research, Volume 13, No. 10, Year 2014
Notification
URL copied to clipboard!
Purpose: To evaluate the role of pre-treatment vitamin D serum level and interleukin28B (IL28B) (rs 12979860) polymorphism in chronic hepatitis C (CHC) genotype 4a patients treated with pegylated interferon α2-A and ribavirin (peg IFN+RBV) as predictors of response.